Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

NCT00290433

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

NCT00309842

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases

NCT00001686

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumors, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

NCT00534118

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB

NCT01953783

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Cleveland, Ohio, United States

View Trial Details

Completed

A Study of LY2835219 in Japanese Participants With Advanced Cancer

NCT02014129

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Tokyo, Japan

View Trial Details

Completed

Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies

NCT02694913

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Weill Medical College of Cornell University New York, United States

View Trial Details

Completed

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)

NCT01889069

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica Bari, Apulia, Italy

Azienda ospedaliera oo rr di foggi; Hematology Foggia, Apulia, Italy

Irccs Crob Rionero in Vulture, Basilicate, Italy

Azienda Ospedaliera Bianchi-Melacrino-Morelli; Unità Operativa di Ematologia Reggio Calabria, Calabria, Italy

View all 39 locations

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

NCT00002715

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States

View Trial Details

Completed

IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT

NCT01885897

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +28 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

Washington University St Louis, Missouri, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions